Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So bid whacked 50k when there was 800k plus on the bid, rookies here.
Agreed! RCLL could be next CTIC monster imo!
Once they file the year end, next week I expect this stock to take off. The problem has been their has been absolutely no news at all with this stock. I am curious about the new distributors that they were adding last year to increase market share. This seemed like this would be very noteworthy at the time. Also they are adding new facilitys (Panama) was one, which would be closer to the U.S.
CTIC (stem cell stock) took off from 0.001 to $1.30 on one big run. Maybe RCLL is the next CTIC?
Once they file the year end, next week I expect this stock to take off. The problem has been their has been absolutely no news at all with this stock. I am curious about the new distributors that they were adding last year to increase market share. This seemed like this would be very noteworthy at the time. Also they are adding new facilitys (Panama) was one, which would be closer to the U.S.
CTIC (stem cell stock) took off from 0.001 to $1.30 on one big run. Maybe RCLL is the next CTIC?
This stock is like the sleeping monster. Calm before the storm!
I agree. Patience needed here. It will pay off in a big way imho.
Once the RCLL .007s are cleared, we are right back up to .0095 (and almost green).
Just hit RCLL for another 10K at .007. NITE is playing 'his' usual games. Still showing 5K available. GLTY.
GLTA RCLL longs.
Nice buys!! NITE definitely has more hidden behind his 5K; just don't know how much.
RCLL
No problem. With NITE showing 5,000 at ASK, just did an AON for 10K at .007. You see the two buys equaling 10K that just occurred. Those are mine. Not sure how many NITE has, but more than 5K. GLTY.
Low volume pullback, just a little over 100K shares.
RCLL
Yes, were holding our own and gradually chewing up the cheapies. Would'nt be surprised if we open at 1.2 cents tomorrow.
Great day today! Markets down yet RCLL holding and trading well.
20,000 shares left at a penny and we move up to 1.2 cents. This will start moving up in a hurry. Thin, Thin, not many shares to be had between here and two cents.
Either way, it won't be long and we will be getting the quarterly to look at. I am hoping for some positive news, at least we know that E is off the end of it.
I remember you from AAVG, well AAVGE now!
Also see you are a Bradley Braves BB fan? I grew up in Iowa and watched Drake play them a few times!
RCLL FORM 12b-25:
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8613294
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date;
...
The Registrant is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2012 within the prescribed period because of a delay in completing the accounting for this period. Final accounting requires additional time to complete and incorporate in the Form 10 Q. Registrant expects to file within the extension period.
Quarterly report to be submitted late.
Hope its encouraging, maybe the reason for the renewed interest in the stock?
Incredible opportunity here. This is a great stock.
Wow we got a huge gem here!
Again, it was called between 0.02 to 0.05 cents on a chart reversal, this doesnt take into account any news. The stock was .55 cents per share last July, so with abit of good news anything is possible.
From @PennyStockGeeks' Twitter feed:
RCLL (RegenoCELL Therapeautics Inc) .011 - This medical Stem Cell stock witha low float of 26 million shares could see up to .10 cents
This stock is moving on its own. Could see up to .05 cents without news imo. Holding tight here. HUGE news can really send it .10 and up imo. Float only 26 million.
I have read it, and yes I agree with you. Penny Whispers called this at 0.02 to 0.05 cents conservatively SHORT TERM on a chart reversal. This is a hot new sector, with some news who knows where it could go.
This is a buy and hold stock. Read the DD. Very very impressive. Stem Cell market is huge. This stock is way undervalued imho.
Their picks have been excellent, they have this one conservatively at 0.02 to 0.05 cents. With some good news this one will go much higher. IMO
Agreed. patient here holding for multi day run $$$$
Looks like MMs want this to start running. Small hits to tick it up, and removing lower ask prices. Few good hits on the ask and we will be in business.
RCLL .011 Hit This baby's slowly trending upwards! She is so thin!
@PennyStockWhispers is calling RCLL as their new alert at .01.
RCLL 0.01: Is Our New Alert. With The "E" Removed From The Ticker And Filing This Stem Cell Company Could Be The Next CTIC
Nice buy. This stock is very thin just 26 million float. Looking for some big gains here $$$$
RCLL .0090 churning slow and steady. This stock moves on air. Looking for .05-.10 cents here!!!
Picked up a position in RCLL this morning.
RCLL (RegenoCell Therapeautics) .01 This stock recently lost its "E" on late filing and the stock since released current filings, with just a 26 million float, this stock caught a major bid late in the day on Friday and could very well be getting ready to release news, the chart is definitely screaming reversal and with the light resistance and low float , this stock could very well trade as high as .03-.05. This stock is currently in the Medical Sector and highly sought out Stem Cell Research.
RCLL Security Details Share Structure
Market Value1 $491,775 a/o May 10, 2012
Shares Outstanding 81,962,500 a/o Nov 15, 2011
Float 26,637,500 a/o Sep 29, 2010
Authorized Shares 520,000,000 a/o Sep 29, 2010
Par Value No Par Value
Chart http://miltonjayro.blogspot.com
Thinking of picking up some RCLL if an opportunity presents itself.
Really hard to tell what kind of gains we could see here. This company is involved in an exciting next generation of medicine.
With a little bit of good news the gains on this stock could get crazy! Right now we have a nice reversal going on the chart, this could be one of those few stocks that you want to keep shares of for quite some time.
Thank you bro. Just saying how I feel of the stock :)
I like the way u think
Wow, extremely undervalued!! imo
.10+ to .50 cents. We are way undervalued imo.
Whats the valuation on RCLL?
RCLL FLOAT Only 26 Million!!!
RCLL #1 STEM CELL Penny Stock Of 2012?
Followers
|
14
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
241
|
Created
|
12/26/07
|
Type
|
Free
|
Moderators |
Market Value1 | $491,775 | a/o May 10, 2012 |
Shares Outstanding | 81,962,500 | a/o Nov 15, 2011 |
Float | 26,637,500 | a/o Sep 29, 2010<----- Float ONLY 26 MILLION! |
Authorized Shares | 520,000,000 | a/o Sep 29, 2010 |
Par Value | No Par Value |
Shareholders of Record | 20 | a/o May 16, 2011 |
Ex. Date | Record Date | Pay Date | |
---|---|---|---|
Dividend (0.00) | Apr 02, 2008 | Mar 31, 2008 | Apr 01, 2008 |
|
Short Interest | 40,000 (0%) Apr 30, 2012 |
Significant Failures to Deliver | No |
Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.
Stem cells are distinguished from other cell types by two important characteristics. First, they are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity. Second, under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions. In some organs, such as the gut and bone marrow, stem cells regularly divide to repair and replace worn out or damaged tissues. In other organs, however, such as the pancreas and the heart, stem cells only divide under special conditions.
Until recently, scientists primarily worked with two kinds of stem cells from animals and humans: embryonic stem cells and non-embryonic "somatic" or "adult" stem cells. The functions and characteristics of these cells will be explained in this document. Scientists discovered ways to derive embryonic stem cells from early mouse embryos nearly 30 years ago, in 1981. The detailed study of the biology of mouse stem cells led to the discovery, in 1998, of a method to derive stem cells from human embryos and grow the cells in the laboratory. These cells are called human embryonic stem cells. The embryos used in these studies were created for reproductive purposes through in vitro fertilization procedures. When they were no longer needed for that purpose, they were donated for research with the informed consent of the donor. In 2006, researchers made another breakthrough by identifying conditions that would allow some specialized adult cells to be "reprogrammed" genetically to assume a stem cell-like state. This new type of stem cell, called induced pluripotent stem cells (iPSCs), will be discussed in a later section of this document.
Stem cells are important for living organisms for many reasons. In the 3- to 5-day-old embryo, called a blastocyst, the inner cells give rise to the entire body of the organism, including all of the many specialized cell types and organs such as the heart, lung, skin, sperm, eggs and other tissues. In some adult tissues, such as bone marrow, muscle, and brain, discrete populations of adult stem cells generate replacements for cells that are lost through normal wear and tear, injury, or disease.
Given their unique regenerative abilities, stem cells offer new potentials for treating diseases such as diabetes, and heart disease. However, much work remains to be done in the laboratory and the clinic to understand how to use these cells for cell-based therapies to treat disease, which is also referred to as regenerative or reparative medicine.
Laboratory studies of stem cells enable scientists to learn about the cells' essential properties and what makes them different from specialized cell types. Scientists are already using stem cells in the laboratory to screen new drugs and to develop model systems to study normal growth and identify the causes of birth defects.
Research on stem cells continues to advance knowledge about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. Stem cell research is one of the most fascinating areas of contemporary biology, but, as with many expanding fields of scientific inquiry, research on stem cells raises scientific questions as rapidly as it generates new discoveries.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |